Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV)’s share price rose 2.9% on Friday . The stock traded as high as $3.25 and last traded at $3.21, with a volume of 72,808 shares trading hands. The stock had previously closed at $3.12.

KTOV has been the topic of several recent research reports. Zacks Investment Research lowered Kitov Pharmaceuticals Holdings from a “buy” rating to a “hold” rating in a report on Tuesday, June 28th. Rodman & Renshaw reaffirmed a “buy” rating on shares of Kitov Pharmaceuticals Holdings in a research report on Monday, July 11th.

The stock’s 50 day moving average is $3.07 and its 200 day moving average is $3.98. The firm’s market cap is $12.53 million.

Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.